Plasma Neurofilament Light Chain and Phosphorylated Tau Are Elevated in Myotonic Dystrophy Type 1. [PDF]
Takahashi MP +12 more
europepmc +1 more source
Brazilian version of the ACTIVLIM: translation, cultural adaptation, and validation for neuromuscular disorders. [PDF]
Santos ACC +5 more
europepmc +1 more source
Validation of the FVB/N-Tg(HSA* LR)20bCath mice of myotonic dystrophy using swallowing function assessment, histology, and immunofluorescence analysis. [PDF]
Asayama R +5 more
europepmc +1 more source
Comprehensive Profiling of Annexins in Neuromuscular Disorders Reveals a Unique Signature in Dysferlinopathy. [PDF]
He QF +11 more
europepmc +1 more source
Fifteen Years of Myotonic Dystrophy Type 1 in Mexico: Clinical, Molecular, and Socioeconomic Insights from a National Reference Cohort. [PDF]
Cerecedo-Zapata CM +12 more
europepmc +1 more source
Video-Based Biomechanical Analysis Captures Disease-Specific Movement Signatures of Different Neuromuscular Diseases. [PDF]
Ruth PS +9 more
europepmc +1 more source
Reduced Muscular Carnosine in Proximal Myotonic Myopathy-A Pilot <sup>1</sup>H-MRS Study. [PDF]
Gussew A +11 more
europepmc +1 more source
Hypertrophic Cardiomyopathy Phenocopies: Classification, Key Features, and Differential Diagnosis. [PDF]
Teresi L +17 more
europepmc +1 more source
Intron 1 of the <i>C9orf72</i> gene: The RNA that RAN. [PDF]
Hagerman PJ.
europepmc +1 more source
Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1. [PDF]
Mishra SK +16 more
europepmc +1 more source

